Immediate medical attention is warranted for symptoms suggesting serious complications, including severe chest pain, difficulty breathing that does not resolve with calming techniques, loss of consciousness, or confusion that may indicate severe hypoglycemia or other acute medical conditions requiring urgent evaluation
Side effects included nausea (31% of patients), diarrhea (23%) and vomiting (12.2%) [26]
Usamos cookies para melhorar sua experincia no Mercado Livre
Common research protocols cited in the peptide community use 1 to 2 mg, 3 to 5 times weekly, over 8 to 12-week cycles
Journal of Neurochemistry, 96(4), 10891101
In 2022, tirzepatide was launched, becoming the worlds first new-generation drug that acts on both GLP-1R/GIPR targets